These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29753403)

  • 1. Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients.
    Jegatheesan D; Cho Y; Johnson DW
    Semin Nephrol; 2018 May; 38(3):277-290. PubMed ID: 29753403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis.
    García-López E; Carrero JJ; Suliman ME; Lindholm B; Stenvinkel P
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S205-9. PubMed ID: 17556305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors.
    Wang AY; Brimble KS; Brunier G; Holt SG; Jha V; Johnson DW; Kang SW; Kooman JP; Lambie M; McIntyre C; Mehrotra R; Pecoits-Filho R
    Perit Dial Int; 2015; 35(4):379-87. PubMed ID: 26228782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Challenges and Opportunities in PD.
    Li PK; Kwong VW
    Semin Nephrol; 2017 Jan; 37(1):2-9. PubMed ID: 28153192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in peritoneal dialysis.
    Prichard S
    Contrib Nephrol; 2003; (140):82-90. PubMed ID: 12800347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dialysis and cardiovascular disease.
    Balafa O; Krediet RT
    Minerva Urol Nefrol; 2012 Sep; 64(3):153-62. PubMed ID: 22971680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
    Refaat H; Sany D; Mohab A; Ezzat H
    Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Cardiovascular Benefits of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysis Fluids: A Review of the Literature.
    Grantham CE; Hull KL; Graham-Brown MPM; March DS; Burton JO
    Perit Dial Int; 2017; 37(4):375-383. PubMed ID: 28676508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors in peritoneal dialysis patients revisited.
    Wang AY
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S223-7. PubMed ID: 17556309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry.
    Rangaswamy D; Guddattu V; Webster AC; Borlace M; Boudville N; Clayton P; Badve S; Johnson DW; Sud K
    Perit Dial Int; 2020 Mar; 40(2):209-219. PubMed ID: 32063201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and glucose homeostasis in peritoneal dialysis.
    Fortes PC; de Moraes TP; Mendes JG; Stinghen AE; Ribeiro SC; Pecoits-Filho R
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S145-8. PubMed ID: 19270204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal Membrane Preservation.
    Bajo MA; Del Peso G; Teitelbaum I
    Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk in the peritoneal dialysis patient.
    Krediet RT; Balafa O
    Nat Rev Nephrol; 2010 Aug; 6(8):451-60. PubMed ID: 20567248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perspectives on treatment of the renal failure].
    Bertolini L; Maggiore U; Savazzi G
    Recenti Prog Med; 2006 Dec; 97(12):759-70. PubMed ID: 17252735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peritoneal dialysis and cardiopulmonary comorbidity].
    Wiesholzer M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():46-53. PubMed ID: 16437333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease.
    Albakr RB; Bargman JM
    Cardiol Clin; 2021 Aug; 39(3):447-453. PubMed ID: 34247757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The
    Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Johnson DW;
    Perit Dial Int; 2017; 37(3):283-289. PubMed ID: 27935537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Goossen K; Becker M; Marshall MR; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Sloand JA; Yao Q; Chang TI; Chen J; Paniagua R; Takatori Y; Wada J; Pieper D
    Am J Kidney Dis; 2020 Jun; 75(6):830-846. PubMed ID: 32033860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.